Speaker illustration

Doctor Jamal Rana

Kaiser Permanente Oakland Medical Centre, Oakland (United States of America)

Member of:

European Society of Cardiology

Jamal Rana MD, PhD, FACC is Chief of Cardiology at the Kaiser Permanente’s Oakland Medical Center, and Immediate Past President of the American College of Cardiology, California Chapter. During his research fellowship at Harvard Medical School, Dr. Rana explored the impact of risk factors such as diabetes and obesity on heart disease. He completed his clinical cardiovascular fellowship at Cedars-Sinai Heart Institute in Beverly Hills. His continuing involvement in research has led to more than 175 peer-reviewed publications in scientific journals and numerous national and international presentations.

Kidney function and future risk of atherosclerotic cardiovascular disease: a study from, approximately half million adults

Event: ESC Congress 2023

Topic: Epidemiology

Session: Risk factors and prevention: epidemiology (1)


Medical therapy for patients presenting with acute heart failure in emergency departments in a large integrated healthcare system.

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Acute heart failure - epidemiology, prognosis, outcome 2


Risk of atherosclerotic cardiovascular disease in patients with premature ASCVD: A study from approximately 1 million young adults

Event: ESC Preventive Cardiology 2023

Topic: Epidemiology

Session: Moderated ePoster 22


Risk of cardiovascular events in a population with type 2 diabetes and metabolic dyslipidemia without atherosclerotic cardiovascular disease receiving statin therapy

Event: EuroPrevent 2018

Topic: Epidemiology

Session: Moderated Poster Session III


Risk of incident atherosclerotic cardiovascular disease events by atherogenic lipid levels in a real-world population of 62,428 on-statin individuals with diabetes

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipid lowering therapy in primary cardiovascular prevention


Prevalence of elevated LDL- cholesterol and the risk of cardiovascular events in a population with established atherosclerotic cardiovascular disease, type 2 diabetes and metabolic dyslipidemia

Event: ESC Congress 2016

Topic: Epidemiology, lipids

Session: Cardiovascular risk in populations


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb